Generation of HSCs in the embryo and assays to detect them

Oncogene
Mervin C Yoder

Abstract

The precise temporal and spatial emergence of hematopoietic stem cells (HSC) in the murine embryo has been somewhat controversial largely due to differences in the assays utilized to demonstrate HSC repopulating ability. One strategy is to determine where and when one can first detect HSC that engraft upon transplantation into lethally irradiated adult mice. However, knowing that the primary sites and patterns of hematopoiesis change during ontogeny, an alternative strategy is to select transplantation models where the recipient subjects more closely mirror the stage of development of the donor cells. In this regard, perhaps the most relevant assay to determine the presence of HSC activity in the early embryo is to transplant the donor cells in utero into recipient embryos. Other recipient models that may permit engraftment of embryonic cells include the use of submyeloablated or genetically HSC deficient newborn mice. Additional informative strategies have included co-culturing embryonic tissues that appear to lack HSC activity, with stromal cells derived from different developmental sites of hematopoiesis to induce HSC emergence, followed by transplantation as a means to determine which embryonic tissues possess HSC potential...Continue Reading

References

Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J F TolesJ E Barker
May 8, 1999·Leukemia·P QuesenberryH Ramshaw
Aug 3, 1999·The Journal of Experimental Medicine·I GodinA Cumano
Apr 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·J PalisM C Yoder
Aug 10, 2001·Experimental Hematology·J Palis, M C Yoder
Oct 31, 2002·Blood·Kathleen E McGrathJames Palis

❮ Previous
Next ❯

Citations

Nov 16, 2013·Experimental & Molecular Medicine·Michael R Copley, Connie J Eaves
Oct 24, 2007·Immunology and Cell Biology·Janice L Abbey, Helen C O'Neill
May 4, 2005·Current Opinion in Hematology·Margaret H Baron, Stuart T Fraser
Jun 10, 2008·Current Opinion in Hematology·Mariusz Z Ratajczak
Mar 20, 2012·Developmental Biology·Jerry M Rhee, Philip M Iannaccone
Nov 30, 2006·Psychology, Health & Medicine·Laura C Nyblade

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.